PMID- 16797033 OWN - NLM STAT- MEDLINE DCOM- 20060829 LR - 20131121 IS - 0024-3205 (Print) IS - 0024-3205 (Linking) VI - 79 IP - 10 DP - 2006 Aug 1 TI - Effect of berberrubine on interleukin-8 and monocyte chemotactic protein-1 expression in human retinal pigment epithelial cell line. PG - 949-56 AB - We examined the effects of berberrubine, a protoberberine alkaloid, on interleukin-8 (IL-8) and monocyte chemotactic protein-1 (MCP-1) expression in a human retinal pigment epithelial cell line (ARPE-19) stimulated with interleukin-1beta (IL-1beta) or tumor necrosis factor alpha (TNF-alpha). ARPE-19 cells were cultured to confluence. Berberrubine and IL-1beta or TNF-alpha were added to the medium. IL-8 and MCP-1 protein concentrations were measured using enzyme-linked immunosorbent assay. IL-8 and MCP-1 mRNA were measured by real time polymerase chain reaction. Nuclear factor kappaB (NF-kappaB) translocation was examined by immunofluorescent staining/microscopy. Berberrubine dose-dependently inhibited IL-8 and MCP-1 protein levels in the media and mRNA expression of the cells stimulated with IL-1beta or TNF-alpha. Immunofluorescent staining/microscopy of NF-kappaB in the nucleus of unstimulated cells was faint (51+/-14 arbitrary units). Fluorescein was dense (215+/-42 or 170+/-24 arbitrary units, respectively) 30 min after stimulation with IL-1beta or TNF-alpha and was decreased to 62+/-18 or 47+/-16 arbitrary units, respectively, by berberrubine. Berberrubine dose-dependently inhibited IL-8 and MCP-1 expression and protein secretion induced by IL-1beta or TNF-alpha. Possibly, the effect on chemotactic factors may be via suppression of NF-kappaB translocation. FAU - Cui, Hu-Shan AU - Cui HS AD - Department of Ophthalmology, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan. ophthal@ms.toyama-mpu.ac.jp FAU - Hayasaka, Seiji AU - Hayasaka S FAU - Zhang, Xue-Yun AU - Zhang XY FAU - Hayasaka, Yoriko AU - Hayasaka Y FAU - Chi, Zai-Long AU - Chi ZL FAU - Zheng, Lian-Shun AU - Zheng LS LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20060512 PL - Netherlands TA - Life Sci JT - Life sciences JID - 0375521 RN - 0 (Chemokine CCL2) RN - 0 (Interleukin-1) RN - 0 (Interleukin-8) RN - 0 (RNA, Messenger) RN - 0 (Transcription Factor RelA) RN - 0 (Tumor Necrosis Factor-alpha) RN - 0I8Y3P32UF (Berberine) RN - 15401-69-1 (berberrubine) SB - IM MH - Berberine/*analogs & derivatives/pharmacology MH - Cell Line MH - Chemokine CCL2/genetics/*metabolism MH - Gene Expression/drug effects MH - Humans MH - Immunohistochemistry MH - Interleukin-1/pharmacology MH - Interleukin-8/genetics/*metabolism MH - Molecular Structure MH - Pigment Epithelium of Eye/cytology/*drug effects/*metabolism MH - Protein Transport/drug effects MH - RNA, Messenger/biosynthesis/genetics MH - Transcription Factor RelA/metabolism MH - Tumor Necrosis Factor-alpha/pharmacology EDAT- 2006/06/27 09:00 MHDA- 2006/08/30 09:00 CRDT- 2006/06/27 09:00 PHST- 2005/12/07 00:00 [received] PHST- 2006/04/25 00:00 [revised] PHST- 2006/05/03 00:00 [accepted] PHST- 2006/06/27 09:00 [pubmed] PHST- 2006/08/30 09:00 [medline] PHST- 2006/06/27 09:00 [entrez] AID - S0024-3205(06)00372-9 [pii] AID - 10.1016/j.lfs.2006.05.004 [doi] PST - ppublish SO - Life Sci. 2006 Aug 1;79(10):949-56. doi: 10.1016/j.lfs.2006.05.004. Epub 2006 May 12.